Cargando…
NIR-I Dye-Based Probe: A New Window for Bimodal Tumor Theranostics
Near-infrared (NIR, 650–1700 nm) bioimaging has emerged as a powerful strategy in tumor diagnosis. In particular, NIR-I fluorescence imaging (650–950 nm) has drawn more attention, benefiting from the high quantum yield and good biocompatibility. Since their biomedical applications are slightly limit...
Autores principales: | Zheng, Fan, Huang, Xueyan, Ding, Jipeng, Bi, Anyao, Wang, Shifen, Chen, Fei, Zeng, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984032/ https://www.ncbi.nlm.nih.gov/pubmed/35402374 http://dx.doi.org/10.3389/fchem.2022.859948 |
Ejemplares similares
-
A plasmon-enhanced theranostic nanoplatform for synergistic chemo-phototherapy of hypoxic tumors in the NIR-II window
por: Chen, Ming-Ming, et al.
Publicado: (2021) -
Functional insights from targeted imaging BACE1: the first near-infrared fluorescent probe for Alzheimer’s disease diagnosis
por: Bi, Anyao, et al.
Publicado: (2022) -
Fluorescent probes for the detection of magnesium ions (Mg(2+)): from design to application
por: Liu, Min, et al.
Publicado: (2018) -
Structural and process controls of AIEgens for NIR-II theranostics
por: Liu, Shunjie, et al.
Publicado: (2020) -
Recent advances in lanthanide-doped up-conversion probes for theranostics
por: Xu, Danyang, et al.
Publicado: (2023)